Magnolia Medical Technologies
Medical Devices, 220 W Mercer St, Seattle, Washington, 98119, United States, 51-200 Employees
Phone Number: 12*********
Who is MAGNOLIA MEDICAL TECHNOLOGIES
Magnolia Medical Technologies is on a Mission to ZERO. Today, we offer healthcare institutions a solution to some of their biggest hidden problems contamination leading to misdiagnosis of...
Read More
-
Headquarters: 220 W Mercer St, Seattle, Washington, 98119, United States
-
Date Founded: 2006
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3841
|
NAICS Code: 339112 |
Show More
Does something look wrong? Fix it. | View contact records from MAGNOLIA MEDICAL TECHNOLOGIES
Magnolia Medical Technologies Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Magnolia Medical Technologies
Answer: Magnolia Medical Technologies's headquarters are located at 220 W Mercer St, Seattle, Washington, 98119, United States
Answer: Magnolia Medical Technologies's phone number is 12*********
Answer: Magnolia Medical Technologies's official website is https://magnolia-medical.com
Answer: Magnolia Medical Technologies's revenue is $50 Million to $100 Million
Answer: Magnolia Medical Technologies's SIC: 3841
Answer: Magnolia Medical Technologies's NAICS: 339112
Answer: Magnolia Medical Technologies has 51-200 employees
Answer: Magnolia Medical Technologies is in Medical Devices
Answer: Magnolia Medical Technologies contact info: Phone number: 12********* Website: https://magnolia-medical.com
Answer: Magnolia Medical Technologies is on a Mission to ZERO. Today, we offer healthcare institutions a solution to some of their biggest hidden problems contamination leading to misdiagnosis of bloodstream infections, including sepsis, which can lead to unnecessary and prolonged antibiotic therapy, and false-positive CLABSIs. Tomorrow, we aspire to create a world free of in-vitro diagnostic errors where rapid, accurate test results improve the lives of patients and providers alike. We know that setting new standards of care is a journey enabled by purposeful innovation, partnerships, and perseverance. As the first step of our journey, we have successfully developed and proven our evidence-based technology platform, Steripath, which weve coupled with unparalleled support to change clinical practices and prevent unnecessary patient harm as well as system-wide costs associated with the misdiagnosis of sepsis. Our mission is further enabled by reducing false-positive CLABSIs and leveraging our extensive intellectual property portfolio consisting of over 100 issued method, apparatus, and design patents and 70+ patent applications pending to address other important sources of diagnostic error that are harmful to patients and costly to hospitals.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month